Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.
about
Parainfluenza virusesIdentification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneThe cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young childrenCurrent approaches to the development of vaccines effective against parainfluenza viruses.Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in childrenEvaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene
P2860
Q24682952-51876A27-C374-42D8-B790-EE939CF9766EQ33641383-35BD3293-94BD-4FD7-8AC3-40F21140E104Q33840469-8FD33DCE-30DA-4215-B0D2-2174095666B9Q34328895-6A4047BC-ABB9-4313-8BD4-413A811B57DDQ36190502-DA78465B-5D96-48D0-B58F-0B49109BA5C1Q36799591-A4352D40-046C-48DA-BF04-8079ADB3B58AQ36812321-04371EA7-72D7-4BC3-8FAD-D89DA6F4CEEAQ37125280-55D176CD-2302-43D8-A220-C479C993A0A9Q37235698-68FE5699-ABF4-4609-8244-6D80C6311651Q37470206-2760336C-189F-43ED-BC9B-34BC481C3BBBQ39869335-48DC07AB-72F2-4D9B-8689-49497ACD8C72Q39873185-A95499A0-B529-49E1-8352-4C9A0AB34399
P2860
Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Protection of weanling hamster ...... old-adapted mutants of para 3.
@en
Protection of weanling hamster ...... ype parainfluenza virus type 3
@nl
type
label
Protection of weanling hamster ...... old-adapted mutants of para 3.
@en
Protection of weanling hamster ...... ype parainfluenza virus type 3
@nl
prefLabel
Protection of weanling hamster ...... old-adapted mutants of para 3.
@en
Protection of weanling hamster ...... ype parainfluenza virus type 3
@nl
P2860
P356
P1476
Protection of weanling hamster ...... old-adapted mutants of para 3.
@en
P2093
Crookshanks-Newman FK
P2860
P304
P356
10.1002/JMV.1890180205
P577
1986-02-01T00:00:00Z